Cedars Sinai Intellectual Property Company sets up its first co-investment partnership outside the US with SEEDS Capital in Singapore
Cedars Sinai Intellectual Property Company sets up its first co-investment partnership outside the US with SEEDS Capital in Singapore
First published 25 May 2023 / Last updated 25 May 2023
Share this article:

: Cedars Sinai Intellectual Property Company sets up its first co-investment partnership outside the US with SEEDS Capital in Singapore

MR No.: 024/23

Cedars Sinai Intellectual Property Company (CSIP), the innovation arm of Cedars-Sinai Medical Centre and SEEDS Capital, the investment arm of Enterprise Singapore, today announced a co-investment partnership to catalyse the development of innovative and disruptive healthcare technology in Asia. The partnership will be done through Coronet Ventures (Singapore) Pte. Ltd (Coronet Ventures), CSIP’s first investment entity outside the US, which focuses on advancing the development of early-stage health and biomedical startups in the region.

Click here to read the full release.